Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.790
-0.010 (-0.56%)
Aug 18, 2026, 10:50 AM EDT - Market open
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,333,133
Market Cap
209.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| ADC Therapeutics | 193 |
CRDL News
- 1 day ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 1 day ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 1 day ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 5 days ago - Cardiol Therapeutics Registration statement: Q2 2026 - Filings
- 5 days ago - Cardiol Therapeutics Registration statement: Q2 2026 - Filings
- 6 days ago - Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial - MarketBeat
- 7 days ago - Cardiol Therapeutics Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 13 days ago - Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference - PRNewsWire